LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only,...

FDA Recall #D-0498-2025 — Class II — June 2, 2025

Recall #D-0498-2025 Date: June 2, 2025 Classification: Class II Status: Ongoing

Product Description

LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only, For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative-Free, For Office Use Only, Compounded Drug by: Medivant Healthcare, 158 S Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0000-0.

Reason for Recall

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Recalling Firm

Tailstorm Health INC — Phoenix, AZ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

29,700 vials

Distribution

Nationwide in the US

Code Information

Lot #s: 2502004, Exp. 2/18/27; 2503003, Exp. 3/19/27

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated